Journalists working on stories related to high-risk pregnancies or the Society for Maternal-Fetal Medicine can contact Greg Phillips, Director of Communications, at press@smfm.org for referrals to MFM experts and to request additional information. The press office is open Monday through Friday from 9:00 AM to 5:00 PM ET.
The Society for Maternal-Fetal Medicine is pleased to announce this year’s awards presented at the SMFM 2026 Pregnancy Meeting™ in Las Vegas, NV. Continue Reading
A novel artificial intelligence (AI) model accurately detected the presence of placenta accreta spectrum (PAS), a dangerous pregnancy condition that often goes undetected with current screening methods, according to new research presented today at the SMFM 2026 Pregnancy Meeting. Continue Reading
Prescribing daily aspirin at the first prenatal visit to all pregnant patients was associated with an overall reduction in the development of severe preeclampsia, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™. Continue Reading
By: Britton D. Rink, MD, MS, and Barton C. Staat, MD The Society for Maternal-Fetal Medicine (SMFM) recently released updated guidelines to help doctors and patients use cell-free DNA (cfDNA) screening more wisely. cfDNA screening is a blood test used during pregnancy to check for certain fetal... Continue Reading
The SMFM Pregnancy Meeting™ returns in 2026 to Las Vegas with the energy, collaboration, and innovation that define our field. Each year, this meeting brings together clinicians, researchers, educators, and trainees united by a shared commitment to improving outcomes for pregnant people... Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) is pleased to announce that Jerasimos Ballas, MD, MPH; Catherine S. Eppes, MD, MPH; Moeun Son, MD, MSCI; and Sarahn M. Wheeler, MD, MHSc, have been elected to the SMFM Board. Continue Reading
By Brian K. Iriye, MD; Vanita D. Jain, MD; and Anthony C. Sciscione, DO What is DFTU and Why Is It Important? The Detailed First-Trimester Ultrasound (DFTU) is a high-resolution scan performed between weeks 12 and 13 of pregnancy to detect fetal structural anomalies.1 It is indicated for... Continue Reading
By Kristen A. Cagino, MD As physicians, we recognize that medical practice is built on a foundation of research. Discovering new therapies, navigating a global pandemic, and identifying the safest, evidence-based management strategy for complex conditions all rely on rigorous, well-designed... Continue Reading
When I was a medical student, the disease process of preeclampsia was one of the things that sparked my interest in the field of obstetrics. Today, I am passionate about teaching patients and their families about preeclampsia because it is one of the most common conditions I manage. What Is... Continue Reading
Media Contact:Karen Addis, APRkaren@addispr.com+1 (301) 787-2394 One of the Largest Studies of its Kind Finds Early Intervention with Iron Delivered Intravenously During Pregnancy is a Safe and Effective Treatment for Anemia Denver, Colo. ― Anemia during pregnancy is a common occurrence and... Continue Reading
Media Contact:Karen Addis, APRkaren@addispr.com+1 (301) 787-2394 New Study Finds High Concentrations of Plastics in the Placentae of Infants Born Prematurely Denver, Colo. ― Microplastics, which are less than 5 millimeters, and nanoplastics, which are invisible to the naked eye, are widespread... Continue Reading
San Francisco, Calif. ― As more states legalize marijuana for recreational use, researchers are looking into the potential health effects of cannabis use during pregnancy. In a new study to be presented today at the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy... Continue Reading
